同期检测血清肝纤维化指标及肝功能。
The levels of the serum markers for liver fibrosis and liver function were also measured.
观察临床症状、肝功能、肝纤维化指标的变化。
T he clinical symptoms, liver function and liver fibrosis indexes were observed.
目的了解血清肝纤维化指标与临床及病理的关系。
Objective to study the relation of hepatic fibrosis indexes to clinic and pathology.
目的探讨血清肝纤维化指标对慢性肝病患者的应用价值。
Objective To investigate the clinical value of serum indices for hepatic fibrosis in chronic liver diseases.
目的探讨卡托普利对早期肝炎肝硬化肝纤维化指标的影响。
Objective to explore the influence of captopril on liver fibrosis index during early-stage viral liver cirrhosis.
慢性肝炎患者肝脏病理分级分期与血清肝纤维化指标存在相关性。
There was a positive correlation between the pathology grade and stage with hepatic fibrosis indexes.
目的探讨肝炎平对兔血吸虫肝纤维化血清中肝纤维化指标的影响。
Objective To study the antifibrotic effect and possible mechanism of Ganyanping on schistosomal liver fibrosis of rabbits after anthelmintic treatment.
目的：观察不同方法治疗肝硬化前后肝血流动力学及肝纤维化指标的变化。
Objictive: To observe the change of liver blood flow and fiber index by different treatment methods in patients with liver cirrhosis.
结论肝硬化患者肝组织质量与肝血流动力学、肝纤维化指标及病理分期有关。
Conclusion liver mass in patients with liver cirrhosis is related to hepatic hemodynamics, indices for liver fibrosis and liver pathology.
结论超声积分及超声与血清肝纤维化指标联合应用对肝纤维化无创定量诊断有较高的价值。
Conclusions Ultrasonography quantitative scoring system, especially when it is combined with serum fibrosis markers, has a higher value in noninvasive quantitative diagnosis of hepatic fibrosis.
血清tnf水平与肝组织学检查肝纤维化程度、肝胶原含量及血清肝纤维化指标HA等相关。
The level of serum TNF was correlated with hepatic fibrosis degree by pathological examination hepatic collagen content and HA etc. parameters of hepatic fibrosis.
结论运用血清学肝纤维化指标评价肝组织纤维化程度时应考虑肝组织炎症程度对肝纤维化指标的影响。
Conclusion the influence of liver inflammation to serum fibrosis markers must be considered when the liver fibrosis staging is evaluated by these markers.
结果：治疗组与对照组比较，其症状消失时间、肝功能复常率、肝纤维化指标改善疗效明显优于对照组。
Results: Compared with control group, in treatment group the period for symptom disappearance was shorter, live function recovery rate was higher...
结果两组患者治疗前肝功能、血浆细胞因子水平及肝纤维化指标间差异无统计学意义（P>0.05）；
Results There were no statistical differences between the two groups on liver function, plasma cytokine and liver fibrosis index before treatment(P>0.05).
目的：观察酒精性肝炎患者使用还原型谷胱甘肽治疗后肝纤维化指标的改善情况及临床症状、体征、肝功能的变化。
AIM: to observe the changes of hepatic fibrosis index, clinical symptom, physical sign and hepatic function after the patients were treated treatment with reduced glutathione hormone.
肝纤维化指标水平，观察组治疗后较治疗前显著下降（P<0.05），而且也显著低于对照组治疗后（P<0.05）。
The hepatic fibrosis indexes were improved significantly in observation group after treatment( P< 0,05), but which were not reduced significantly in control group.
为观察慢性乙型肝炎患者的肝脾超声与血清肝纤维化指标的相关性，检查62例慢性乙型肝炎患者肝脾超声、血清肝纤维化指标。
To observe the correlativity between hepatosplenic ultrasonic results and liver fibrosis indexes in patients with hepatitis B, they were detected in 62 subjects.
方法：用鸭乙型肝炎病毒（DHBV）阳性血清反复攻击复制鸭乙型肝炎肝纤维化模型，同时用剔毒护肝方治疗，观察其对肝纤维化指标的影响。
Methods: Duck models with hepatic fibrosis were induced by duck hepatitis B Virus (DHBV) and meanwhile treated with Tidu Hugan Decoction. The indexes of hepatic fibrosis were assaged.
动态观察上述指标的变化既可掌握患者病情的演变，也为抗肝纤维化药物的筛选奠定基础。
The dynamic changement of three markers may be used to predict the trends of diseases and select effective medicine treating hepatic fibrosis.
目的研究空腹血清总胆汁酸(TBA)与血清纤维化指标和肝组织病理关系。
Objective to study the correlation between total serum bile acid (TBA) and the liver histology.
超声分级级别越高，血清肝纤维化4项指标含量越高。
The more advanced the ultrasonic scales of liver fibrosis, the higher level the 4 serum indicators.
结果：在肝炎向肝硬化转变的过程中，每一个时期均可见到肝纤维化四项指标中的一项或几项的升高。
Result: During the change of hepatitis to cirrhosis, we can discover one or more of the four indexes rise in every phase.
四项指标与肝组织炎症坏死及纤维化程度均呈显著相关（P<0.05）。
There were significant correlation(P<0.05) between the four indexes and the degree of inflammation, necrosis and fibrosis.
目的明确肝纤维化血清学指标对诊断肝纤维化的临床价值。
Objective To evaluate the clinical value of serum fibrosis index in the diagnosis of hepatic fibrosis.
目的比较肝硬变病人不同方法治疗前后，肝血流量与肝纤维化等项指标的改变。
Objective to compare the changes of liver blood flow and liver fibrosis in patients with hepatocirrhosis by ant I fibrosis treatment.
提示血清HA含量是早期判断肝细胞损伤和肝纤维化程度的有用指标。
The results suggest that immunoassay for HA in serum is a more sensitive index for liver cell damage and hepatic fibrosis.
目的探讨慢性肝炎肝纤维化血清学指标与病理之间的关系。
Purpose To appraise the relationships between serum markers of liver fibrosis and pathological changes in chronic hepatitis.
此文对肝组织学活检、血清学指标、影像学指标及多参数模型诊断肝纤维化的相关研究进展进行综述。
This paper will review the researches of hepatic fibrosis diagnosis by hepatic biopsy, serological indexes, imagine examinations and models included several indexes.
与对照组相比，治疗组患者肝纤维化的指标改善及HBVDNA低于检测下限的比率更为显著。
Compared with the control group, the improvment of liver fibrosis index and HBV DNA negative rate of patients in therapy group were more obvious.
与对照组相比，治疗组患者肝纤维化的指标改善及HBVDNA低于检测下限的比率更为显著。
Compared with the control group, the improvment of liver fibrosis index and HBV DNA negative rate of patients in therapy group were more obvious.
应用推荐